Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

QR Pharma commences clinical trial of Posiphen in early stage AD patients

QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer’s disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.

10 Feb 2010

Study calls for improved decision-making in using feeding tubes in dementia patients

Researchers from Brown University and Harvard Medical School are calling for improved decision-making in the use of feeding tubes for hospitalized nursing home residents with advanced dementia.

10 Feb 2010

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

A medication previously studied in patients with Alzheimer's disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington's disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Feb 2010

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Scientists have determined that a new instrument known as PIB-PET is effective in detecting deposits of amyloid-beta protein plaques in the brains of living people, and that these deposits are predictive of who will develop Alzheimer's disease.

10 Feb 2010

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).

10 Feb 2010

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan Corporation, plc today reported its fourth quarter and full-year 2009 financial results and provides financial guidance for 2010.

10 Feb 2010

APA releases proposed draft diagnostic criteria for DSM-5

The American Psychiatric Association today released the proposed draft diagnostic criteria for the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM). The draft criteria represent content changes under consideration for DSM, which is the standard classification of mental disorders used by mental health and other health professionals, and is used for diagnostic and research purposes.

10 Feb 2010

Maternal obesity increases offspring's risk of developing inflammation-related disorders

As if there are not enough reasons for obese people to lose weight, a new research report published online in The FASEB Journal (http://www.fasebj.org), adds several more. In a study involving rats, researchers from Duke University found that obesity in mothers causes cellular programming in utero that predisposes offspring to inflammation-related disorders (such as Alzheimer's, Parkinson's, type 2 diabetes, stroke, heart disease, and more) from the day that they are born, regardless of whether or not the offspring are obese themselves.

10 Feb 2010

Drinking milk during pregnancy can protect baby against multiple sclerosis

Drinking milk during pregnancy may help reduce your baby's chances of developing multiple sclerosis (MS) as an adult, according to a preliminary study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

10 Feb 2010

New European-developed system may help dementia patients to lead independent lives

Tens of millions of elderly people in the EU suffering from mild dementia may be able to look after themselves, and free up their carers, thanks to a new European-developed system.

9 Feb 2010

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: “Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson’s Disease Biomarker” and is the second awarded to Targacept by MJFF in the last six months.

9 Feb 2010

Vigilan announces new continuing education courses for assisted living community administrators

Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.

9 Feb 2010

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

A Mediterranean diet may help people avoid the small areas of brain damage that can lead to problems with thinking and memory, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

9 Feb 2010

KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer’s disease

KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in the area of Alzheimer’s disease and other neurodegenerative conditions.

9 Feb 2010

Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedule

Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.

9 Feb 2010

High BP may predict dementia in older adults with cognitive impairment

High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Feb 2010

Dimebon drug associated with improved cognitive function in patients with Huntington's disease

An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of Neurology.

9 Feb 2010

Marijuana ineffective against Alzheimer's disease in animal model

The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.

8 Feb 2010

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

7 Feb 2010

10 helpful tips to safeguard Alzheimer's patients

An ID bracelet, like the one offered through the Alzheimer's Association's MedicAlert + Safe Return program, helps the police or a Good Samaritan get a missing person back home safely or medical attention.

5 Feb 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

QR Pharma commences clinical trial of Posiphen in early stage AD patients

Study calls for improved decision-making in using feeding tubes in dementia patients

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

APA releases proposed draft diagnostic criteria for DSM-5

Maternal obesity increases offspring's risk of developing inflammation-related disorders

Drinking milk during pregnancy can protect baby against multiple sclerosis

New European-developed system may help dementia patients to lead independent lives

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Vigilan announces new continuing education courses for assisted living community administrators

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer’s disease

Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedule

High BP may predict dementia in older adults with cognitive impairment

Dimebon drug associated with improved cognitive function in patients with Huntington's disease

Marijuana ineffective against Alzheimer's disease in animal model

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

10 helpful tips to safeguard Alzheimer's patients

Aneuro: A Year of Neuroscience in Review eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: A Year of Neuroscience in Review eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in